More specifically, the Regan score combines seven classic clinicopathologic features (age, tumor size, nodal status, grade, estrogen receptor level, progesterone receptor level, and Ki-67 expression level) into a single continuous value that represents differences in outcomes between various ET combinations. The gene discussed is PGR; the disease is neoplasm.